TABLE 1.

Azole susceptibility of adapted C. albicans strainsa

StrainMICb (μg ml−1) of:Source
FLCITRAKETOTERBNYS
YO1-16160.1250.031250.55NDDR, Ranbaxy India
YO1-32320.250.062515This study
YO1-64640.250.062525This study
  • a MICs were determined by a microdilution method and by reading end points after a 48-h incubation of plates at 37°C as described in Materials and Methods. FLC, fluconazole; ITRA, itraconazole; KETO, ketoconazole; TERB, terbinafine; NYS, nystatin.

  • b MIC test end point was defined as the lowest drug concentration that gave >80% inhibition of growth.